Logo image of WINT

WINDTREE THERAPEUTICS INC (WINT) Stock Fundamental Analysis

NASDAQ:WINT - Nasdaq - US97382D5014 - Common Stock - Currency: USD

0.16  +0.02 (+13.15%)

After market: 0.215 +0.05 (+34.38%)

Fundamental Rating

0

Taking everything into account, WINT scores 0 out of 10 in our fundamental rating. WINT was compared to 572 industry peers in the Biotechnology industry. WINT has a bad profitability rating. Also its financial health evaluation is rather negative. WINT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WINT has reported negative net income.
In the past year WINT has reported a negative cash flow from operations.
WINT had negative earnings in each of the past 5 years.
In the past 5 years WINT always reported negative operating cash flow.
WINT Yearly Net Income VS EBIT VS OCF VS FCFWINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

The Return On Assets of WINT (-35.17%) is better than 61.95% of its industry peers.
The Return On Equity of WINT (-163.47%) is worse than 66.37% of its industry peers.
Industry RankSector Rank
ROA -35.17%
ROE -163.47%
ROIC N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
WINT Yearly ROA, ROE, ROICWINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for WINT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WINT Yearly Profit, Operating, Gross MarginsWINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

WINT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WINT has more shares outstanding
WINT has a worse debt/assets ratio than last year.
WINT Yearly Shares OutstandingWINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
WINT Yearly Total Debt VS Total AssetsWINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -42.18, we must say that WINT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -42.18, WINT is not doing good in the industry: 93.98% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.12 indicates that WINT is not too dependend on debt financing.
WINT has a Debt to Equity ratio of 0.12. This is in the lower half of the industry: WINT underperforms 67.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -42.18
ROIC/WACCN/A
WACCN/A
WINT Yearly LT Debt VS Equity VS FCFWINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

WINT has a Current Ratio of 0.27. This is a bad value and indicates that WINT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.27, WINT is not doing good in the industry: 96.11% of the companies in the same industry are doing better.
A Quick Ratio of 0.27 indicates that WINT may have some problems paying its short term obligations.
With a Quick ratio value of 0.27, WINT is not doing good in the industry: 95.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
WINT Yearly Current Assets VS Current LiabilitesWINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.29% over the past year.
EPS 1Y (TTM)98.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-544.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, WINT will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.26% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.66%
EPS Next 2Y31.47%
EPS Next 3Y24.34%
EPS Next 5Y-10.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WINT Yearly Revenue VS EstimatesWINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
WINT Yearly EPS VS EstimatesWINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -5K -10K -15K -20K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WINT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WINT Price Earnings VS Forward Price EarningsWINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WINT Per share dataWINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

WINT's earnings are expected to grow with 24.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.47%
EPS Next 3Y24.34%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WINDTREE THERAPEUTICS INC

NASDAQ:WINT (2/11/2025, 7:44:53 PM)

After market: 0.215 +0.05 (+34.38%)

0.16

+0.02 (+13.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)N/A N/A
Inst Owners1.42%
Inst Owner Change-96.53%
Ins Owners0.68%
Ins Owner Change0.01%
Market Cap1.44M
Analysts43.33
Price Target7.14 (4362.5%)
Short Float %10.15%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-146.03%
Min EPS beat(2)-152.79%
Max EPS beat(2)-139.27%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-225.71%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8
EYN/A
EPS(NY)-2.17
Fwd EYN/A
FCF(TTM)-1.7
FCFYN/A
OCF(TTM)-1.7
OCFYN/A
SpS0
BVpS0.73
TBVpS-2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.17%
ROE -163.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.64%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -42.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)55.35%
Cap/Depr(5y)88.07%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-544.19%
EPS Next Y69.66%
EPS Next 2Y31.47%
EPS Next 3Y24.34%
EPS Next 5Y-10.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.23%
OCF growth 3YN/A
OCF growth 5YN/A